Comparison of treatment results of prostatic cancer between radical prostatectomy and radiation therapy

Between 1982 and 1990, 55 patients with prostate cancer (clinical stage A2-C) underwent pelvic lymphadenectomy at the Public Toyooka Hospital. The patients were subsequently treated either by radical prostatectomy (36 cases) or external radiation therapy (19 cases). The age of the patients varied fr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 40(1994), 9 vom: 13. Sept., Seite 795-801
1. Verfasser: Kanamaru, H (VerfasserIn)
Weitere Verfasser: Arai, Y, Moroi, S, Shirahase, T, Isogawa, Y, Okuno, H, Kihara, Y, Kuo, J Y, Taniguchi, T, Takeuchi, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1994
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Comparative Study English Abstract Journal Article
Beschreibung
Zusammenfassung:Between 1982 and 1990, 55 patients with prostate cancer (clinical stage A2-C) underwent pelvic lymphadenectomy at the Public Toyooka Hospital. The patients were subsequently treated either by radical prostatectomy (36 cases) or external radiation therapy (19 cases). The age of the patients varied from 56 to 85 (Mean 73.1). The outcome of the 46 patients with negative lymph node (prostatectomy 31, radiation 15) were compared. The 10-year disease-specific survival rates were 100% for the patients treated by prostatectomy and 78% for those treated by radiation (P = 0.035). The 5-year progression-free survival rates for the prostatectomy group and radiation group were 97% and 56%, respectively (P = 0.013). Among the radiation groups, patients with well differentiated carcinoma showed a lower progression rate as compared to those with moderately or poorly differentiated carcinoma (5-year progression-free survival, 81 vs 20%, P = 0.094). The outcome of the 9 patients with positive lymph node (prostatectomy 5, radiation 4) was not satisfactory because of the high progression rates in the two groups (5 year progression-free survival, 30% in prostatectomy and 25% in radiation group)
Beschreibung:Date Completed 20.01.1995
Date Revised 15.11.2006
published: Print
Citation Status MEDLINE
ISSN:0018-1994